Correlation Between Bristol Myers and Radient Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Radient Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Radient Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Radient Technologies, you can compare the effects of market volatilities on Bristol Myers and Radient Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Radient Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Radient Technologies.

Diversification Opportunities for Bristol Myers and Radient Technologies

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Bristol and Radient is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Radient Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Radient Technologies and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Radient Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Radient Technologies has no effect on the direction of Bristol Myers i.e., Bristol Myers and Radient Technologies go up and down completely randomly.

Pair Corralation between Bristol Myers and Radient Technologies

If you would invest  84,500  in Bristol Myers Squibb on October 23, 2024 and sell it today you would earn a total of  9,022  from holding Bristol Myers Squibb or generate 10.68% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy96.72%
ValuesDaily Returns

Bristol Myers Squibb  vs.  Radient Technologies

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile primary indicators, Bristol Myers reported solid returns over the last few months and may actually be approaching a breakup point.
Radient Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Radient Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Radient Technologies is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Bristol Myers and Radient Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol Myers and Radient Technologies

The main advantage of trading using opposite Bristol Myers and Radient Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Radient Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Radient Technologies will offset losses from the drop in Radient Technologies' long position.
The idea behind Bristol Myers Squibb and Radient Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
CEOs Directory
Screen CEOs from public companies around the world
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing